MASSARELLI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.508
EU - Europa 804
AS - Asia 340
AF - Africa 73
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.733
Nazione #
US - Stati Uniti d'America 1.454
IT - Italia 224
CN - Cina 176
DE - Germania 117
SE - Svezia 105
GB - Regno Unito 76
BG - Bulgaria 73
SG - Singapore 70
TR - Turchia 60
AT - Austria 56
CA - Canada 54
UA - Ucraina 54
CH - Svizzera 29
CI - Costa d'Avorio 28
FI - Finlandia 28
SN - Senegal 27
FR - Francia 25
VN - Vietnam 21
NG - Nigeria 16
RU - Federazione Russa 11
BR - Brasile 6
HK - Hong Kong 6
IN - India 5
BE - Belgio 2
BJ - Benin 2
IR - Iran 2
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
LU - Lussemburgo 1
PE - Perù 1
PT - Portogallo 1
Totale 2.733
Città #
Ann Arbor 234
Woodbridge 221
Chandler 152
Houston 149
Milan 105
Jacksonville 91
Fairfield 77
Sofia 73
Ashburn 71
Beijing 64
Vienna 56
Ottawa 49
Izmir 46
New York 40
Wilmington 39
Florence 36
Nanjing 34
Singapore 34
Lancaster 32
Bern 29
Abidjan 28
Boardman 28
Princeton 28
Dakar 27
Lawrence 27
Santa Clara 27
Seattle 26
Cambridge 23
London 21
Jüchen 20
Marseille 20
Lagos 16
Medford 14
Nanchang 14
Istanbul 13
Shenyang 12
Dearborn 11
Des Moines 11
Dong Ket 11
Boulder 9
Rome 9
Tianjin 7
Falls Church 6
Hong Kong 6
Orange 6
Auburn Hills 5
Pune 5
Bremen 4
Changsha 4
Kunming 4
Ogden 4
San Diego 4
Shanghai 4
Toronto 4
Fuzhou 3
Jiaxing 3
Los Angeles 3
Norwalk 3
Quanzhou 3
Verona 3
Washington 3
Brussels 2
Changchun 2
Cotonou 2
Dallas 2
Hangzhou 2
Hebei 2
Hefei 2
Kansas City 2
Munich 2
Nova Iguaçu 2
Redwood City 2
San Francisco 2
Shenzhen 2
Tehran 2
Xiamen 2
Americana 1
Bovisio Masciago 1
Campos do Jordão 1
Catolé do Rocha 1
Charlotte 1
Chengdu 1
Council Bluffs 1
Forlimpopoli 1
Guangzhou 1
Hanoi 1
Helsinki 1
Indiana 1
Jinan 1
Jinhua 1
Leawood 1
Lima 1
Lisbon 1
Luxembourg 1
Milton Keynes 1
Montreal 1
Moreilândia 1
Ningbo 1
Nürnberg 1
Phoenix 1
Totale 2.165
Nome #
Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells 213
IN VITRO ANTICANCER ACTIVITY OF E. PALLIDA POLYACETILENES 170
Design of fibrin-specific ligands for drug targeting 151
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 141
Development of Classification Model batteries for predicting inhibition of tubulin polymerization by small molecules 141
Binding mode of Adenosine Deaminase inhibitors and zinc modeling 124
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals 120
Optimizing QSAR Models for Predicting Ligand Binding to the Drug-Metabolizing Cytochrome P450 Isoenzyme CYP2D6 120
Nanoparticles for smart drug delivery system: computational approach for the design of fibrinolytic drugs 116
Characterization of enzyme kinetics of human Cathepsin L 110
Development of QSAR models for predicting inhibition of tubulin polymerization in the design of anticancer drugs 102
Ligand Design for the g(312-324) epitope of fibrin 101
Prediction of HERG Potassium Channel Affinity by Traditional QSAR and Volsurf Approach 100
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 97
Understanding mechanism of selectivity between Gal- and Man-type ligands showed by human asialoglycoprotein receptor in view of predicting its interactions with exogenous sugars 93
Insights into interactions between fibrin and peptidic ligands 89
HIGH-THROUGHPUT DOCKING AS A TOOL FOR VIRTUAL SCREENING AND FLUORIMETRIC ASSAYS AIMED AT IDENTIFYING FIBRIN LIGANDS 89
Computational studies of human Cathepsin L inhibition 82
New applications in cancer therapy: design of ligands for cathepsin L 81
Theoretical Studies of Interactions between Chelidocystatin and human Cathepsins for potential applications in cancer therapy 79
Identification of selective ligands for human fibrin recognition by means of High-Throughput Docking 78
Understanding selectivity mechanism of human asialoglycoprotein receptor (ASGP-R) toward Gal- and Man-type ligands for predicting interactions with exogenous sugars 68
STUDI TEORICI D’INTERAZIONE TRA NUOVI COMPOSTI E CATEPSINA L UMANA PER POTENZIALI APPLICAZIONI NELLA TERAPIA ONCOLOGICA 66
Design of Highly Specified Ligands of Fibrin for Therapeutic Applications 63
Three-dimensional models of the oligomeric human Asialoglycoprotein Receptor (ASGP-R) 58
Computer-Aided Design of Fibrin-Specific Liganda and Preliminary Experimental Validation 50
Studio d’ interazione dell’ epitopo g(312-324) della fibrina umana con ligandi peptidici 39
Totale 2.741
Categoria #
all - tutte 6.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 31 25 30 17 32 40 39 2
2020/2021129 24 3 14 3 21 1 17 12 4 5 3 22
2021/2022231 3 22 2 10 52 34 5 8 8 2 16 69
2022/2023543 40 66 40 43 77 66 2 25 129 0 43 12
2023/2024342 65 50 46 22 51 63 4 4 5 1 7 24
2024/2025152 2 35 6 65 44 0 0 0 0 0 0 0
Totale 2.741